ITEM 7.01 Regulation FD Disclosure

On February 25, 2020, Zynex, Inc. issued a press release announcing the U.S. Food and Drug Administration ("FDA") granted 510(k) clearance for sale in the U.S. of the Company's CM-1500 Blood Volume Monitor. A copy of the press release is furnished herewith as Exhibit 99.1.

The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS






d)    Exhibits. The following exhibits are filed with this report.



Exhibit No.                        Description

99.1 Zynex, Inc. Press Release dated February 25, 2020

© Edgar Online, source Glimpses